Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TPB | AIP |
|---|---|---|
| Price | $57.37 | $23.40 |
| Change today | ▼ 1.54% | ▼ 3.03% |
| Market cap | $1.15B | $1.15B |
| Return, 3 months | -34.8% | -35.2% |
| Return, year to date | -46.9% | +51.0% |
| Return, 1 year | -32.3% | +73.5% |
| P/E (TTM) | 24.9 | -26.9 |
| P/B | 2.7 | 17.0 |
| P/E percentile vs own 5y | 46th | 14th |
| Dividend yield | 0.54% | – |
| Revenue growth (YoY, latest qtr) | +22.6% | +46.2% |
| Net profit growth (YoY) | -39.3% | -54.1% |
| Gross margin | 59.2% | 87.6% |
| Operating margin | 14.8% | -44.4% |
| Net margin | 8.8% | -46.7% |
| Return on equity | 13.7% | -131.4% |
| Analyst target vs. price | +99.1% | +68.5% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 28 | 48 |
| 30-day volatility | 43.8% | 59.8% |
| Max drawdown, 1 year | -61.2% | -58.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
